170 companies

Eli Lilly

Market Cap: US$1.1t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

LLY

US$1,215.02

7D

8.9%

1Y

90.0%

Johnson & Johnson

Market Cap: US$630.9b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

JNJ

US$259.80

7D

1.9%

1Y

50.4%

AbbVie

Market Cap: US$438.2b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

ABBV

US$250.09

7D

2.6%

1Y

25.9%

Merck

Market Cap: US$323.0b

Operates as a healthcare company worldwide.

MRK

US$130.42

7D

1.9%

1Y

62.4%

AstraZeneca

Market Cap: UK£183.7b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

AZN

UK£118.44

7D

0.9%

1Y

6.8%

Amgen

Market Cap: US$225.6b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

AMGN

US$414.30

7D

6.2%

1Y

45.4%

Bristol-Myers Squibb

Market Cap: US$132.4b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

BMY

US$63.61

7D

-3.5%

1Y

36.6%

Chugai Pharmaceutical

Market Cap: JP¥11.7t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

4519

JP¥7,112.00

7D

6.5%

1Y

15.1%

WuXi AppTec

Market Cap: CN¥475.7b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

603259

CN¥160.21

7D

13.3%

1Y

75.1%

Jiangsu Hengrui PharmaceuticalsLtd

Market Cap: CN¥362.5b

A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

600276

CN¥54.97

7D

2.9%

1Y

-9.7%

Galderma Group

Market Cap: CHF 42.3b

Operates as a dermatology company worldwide.

GALD

CHF 181.35

7D

3.2%

1Y

39.4%

CSL

Market Cap: AU$66.2b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

CSL

AU$138.33

7D

7.4%

1Y

-47.7%

Natera

Market Cap: US$45.9b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

New

NTRA

US$312.72

7D

13.6%

1Y

95.7%

Haleon

Market Cap: UK£32.5b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

HLN

UK£3.69

7D

1.7%

1Y

4.0%

Teva Pharmaceutical Industries

Market Cap: US$42.1b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

TEVA

US$36.48

7D

6.0%

1Y

119.8%

Otsuka Holdings

Market Cap: JP¥6.6t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

4578

JP¥12,560.00

7D

4.5%

1Y

59.6%

Waters

Market Cap: US$39.9b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

WAT

US$406.86

7D

7.8%

1Y

44.7%

IQVIA Holdings

Market Cap: US$39.3b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

IQV

US$241.99

7D

3.7%

1Y

34.4%

Sandoz Group

Market Cap: CHF 31.5b

Develops, manufactures, and markets generic and biosimilars worldwide.

SDZ

CHF 72.78

7D

10.7%

1Y

53.9%

Daiichi Sankyo Company

Market Cap: JP¥5.1t

Manufactures and sells pharmaceutical products in Japan and internationally.

4568

JP¥2,805.00

7D

9.1%

1Y

-21.0%

Illumina

Market Cap: US$28.4b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

ILMN

US$191.79

7D

-3.2%

1Y

102.4%

Hansoh Pharmaceutical Group

Market Cap: HK$211.1b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

3692

HK$34.82

7D

10.9%

1Y

-3.5%

Astellas Pharma

Market Cap: JP¥4.2t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

4503

JP¥2,363.00

7D

8.6%

1Y

46.3%

WuXi Biologics (Cayman)

Market Cap: HK$188.7b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil.

New

2269

HK$45.98

7D

13.6%

1Y

55.5%

Innovent Biologics

Market Cap: HK$166.3b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

New

1801

HK$95.55

7D

10.2%

1Y

9.5%

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$126.3b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.

New

6990

HK$528.50

7D

9.7%

1Y

30.9%

Ipsen

Market Cap: €13.2b

A biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience in North America, Europe, and internationally.

IPN

€161.60

7D

-3.3%

1Y

52.0%

Eurofins Scientific

Market Cap: €12.1b

Provides various analytical testing and laboratory services worldwide.

ERF

€69.80

7D

2.4%

1Y

5.0%

Orion Oyj

Market Cap: €11.5b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€81.50

7D

0.5%

1Y

24.6%

Revvity

Market Cap: US$12.8b

Provides health sciences solutions, technologies, and services.

RVTY

US$114.66

7D

1.9%

1Y

32.0%

ICON

Market Cap: US$12.7b

A clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.

ICLR

US$164.51

7D

0.6%

1Y

3.8%

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.9b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

REC

€53.25

7D

3.1%

1Y

7.1%

Akeso

Market Cap: HK$93.9b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

9926

HK$101.90

7D

8.6%

1Y

-34.9%

Elanco Animal Health

Market Cap: US$11.1b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

ELAN

US$22.12

7D

-16.1%

1Y

32.7%

WuXi XDC Cayman

Market Cap: HK$81.4b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

2268

HK$64.25

7D

16.1%

1Y

12.3%

Dr. Reddy's Laboratories

Market Cap: ₹978.8b

Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.

500124

₹1,175.00

7D

2.7%

1Y

-2.1%

Page 1 of 5